UroGen Pharma Ltd. (URGN)
18.59
+0.11
(+0.60%)
USD |
NASDAQ |
Mar 19, 16:00
18.74
+0.15
(+0.81%)
After-Hours: 06:34
UroGen Pharma Total Assets (Quarterly) : 200.46M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| RadNet, Inc. | 4.008B |
| Zymeworks, Inc. | 346.53M |
| Xeris Biopharma Holdings, Inc. | 392.94M |
| Caribou Biosciences, Inc. | 179.63M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 305.93M |
| Shareholders Equity (Quarterly) | -105.47M |
| Debt to Equity Ratio | -1.233 |
| Current Ratio | 4.008 |
| Net Debt Paydown Yield | -0.13% |